#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Multifocal motor neuropathy Raynaud's phenomenon Necrotising enterocolitis neonatal Anal fistula Infection in an immunocompromised host Li-Fraumeni syndrome Mantle cell lymphoma recurrent Metastatic malignant melanoma Neonatal asphyxia Dilated cardiomyopathy Oesophageal adenocarcinoma stage II Pleural mesothelioma malignant Dermatomyositis Angiosarcoma non-metastatic Aicardi-Goutieres syndrome More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Haemolytic uraemic syndrome – Diagnostics Synovial sarcoma recurrent – Treatment Mucopolysaccharidosis I – Trials in Disease Basal cell naevus syndrome – Life with Disease Haemophilia A without inhibitors – Treatment Mucous membrane pemphigoid – Life with Disease Activated PI3 kinase delta syndrome – Treatment Retinoblastoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Taplucainium Chloride Tas3351 Acetylsalicylic Acid Warfarin Sodium Mitomycin Prax-628 Azd8205 [18F]Mc225 Dobutamine Hydrochloride Vibegron CAL101 Dyp688 Epinephrine SAR443820 Ipratropium Bromide Olopatadine Navitoclax Sarilumab Ofatumumab USNOFLAST More therapies…

    Learn about Your Condition

    Metastases to peritoneum Nicotine dependence Dyspepsia Multiple sclerosis relapse HER2 positive breast cancer Oesophageal adenocarcinoma Paraesthesia Mucopolysaccharidosis II Hereditary optic atrophy Mantle cell lymphoma stage II Fatty acid oxidation disorder Ewing's sarcoma Enteritis Ebola disease Dengue fever More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hospital Universitari General De Catalunya

Hospital Universitari General De Catalunya

Carrer Pedro I Pons 1, Sant Cugat Del Valles, 08195, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Clesrovimab and Palivizumab for Preventing Severe RSV in Infants and Children at High Risk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • CLESROVIMAB
    • Palivizumab
    • Sodium Chloride
    Czechia Finland France Germany Greece Hungary +3

  • Study of CVN424 for Reducing Motor Complications in Parkinson’s Disease Patients

    Not recruiting

    2 1
    Investigated Drugs:
    • 1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE
    Czechia France Italy Poland Spain

  • Study on the Safety and Effects of BIIB122 for Patients with LRRK2-Associated Parkinson’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine
    Germany Spain

  • Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • Exemestane
    • Everolimus
    Belgium Bulgaria Czechia Denmark Finland France +8

  • Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson’s Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    Austria France Italy Luxembourg Poland Spain

  • Study of BMS-986446 for Early Alzheimer’s Disease Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Prx005
    • Florquinitau (18F)
    Belgium Spain Sweden

  • Study Comparing Ribociclib and Palbociclib for Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Palbociclib
    • Ribociclib
    • Tislelizumab
    Portugal Spain

  • Study on the Effectiveness of OPT-302 and Ranibizumab for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    • Vascular Endothelial Growth Factor Receptor 3 Extracellular Domains 1-3 Fused To A Igg1 Fc Fragment
    Czechia Denmark France Germany Greece Hungary +4

  • Safety Study of Almagate for Pregnant Women with Heartburn and Reflux, Assessing Effects on Mother and Baby

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dyspepsia
    • Gastrooesophageal reflux disease
    Investigated Drugs:
    • Almagate
    Spain

  • Study on Palbociclib and Drug Combination for Patients with Hormone Receptor Positive, HER2-Positive Metastatic Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Goserelin
    France Germany Italy Portugal Spain
Previous Page
1 … 3 4 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!